Report for: Chromium picolinate supplementation for overweight or obese adults

Title	Chromium picolinate supplementation for overweight or obese adults
Published in	Cochrane database of systematic reviews, November 2013
DOI	10.1002/14651858.cd010063.pub2
Pubmed ID	24293292
Authors	Hongliang Tian, Xiaohu Guo, Xiyu Wang, Zhiyun He, Rao Sun, Sai Ge, Zongjiu Zhang
Abstract	Obesity is a global public health threat. Chromium picolinate (CrP) is advocated in the medical literature for the reduction of bodyweight, and preparations are sold as slimming aids in the USA and Europe, and on the Internet.

View on publisher site Alert me about new mentions

Twitter Demographics

The data shown below were collected from the profiles of 23 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Country	Count	As %
United States	2	9%
Spain	2	9%
United Kingdom	1	4%
Mexico	1	4%
Sao Tome and Principe	1	4%
India	1	4%
Ecuador	1	4%
Italy	1	4%
Netherlands	1	4%
Other	0	0%
Unknown	12	52%

Demographic breakdown

Type	Count	As %
Members of the public	18	78%
Practitioners (doctors, other healthcare professionals)	4	17%
Scientists	1	4%

Mendeley readers

The data shown below were compiled from readership statistics for 499 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country	Count	As %
Brazil	4	<1%
United Kingdom	2	<1%
Netherlands	1	<1%
Ireland	1	<1%
Chile	1	<1%
Malaysia	1	<1%
Canada	1	<1%
Singapore	1	<1%
United States	1	<1%
Other	1	<1%
Unknown	485	97%

Demographic breakdown

Readers by professional status	Count	As %
Student > Master	103	21%
Student > Bachelor	70	14%
Researcher	57	11%
Student > Ph. D. Student	49	10%
Student > Doctoral Student	28	6%
Other	88	18%
Unknown	104	21%

Readers by discipline	Count	As %
Medicine and Dentistry	139	28%
Nursing and Health Professions	77	15%
Agricultural and Biological Sciences	24	5%
Social Sciences	20	4%
Sports and Recreations	19	4%
Other	92	18%
Unknown	128	26%

Attention Score in Context

This research output has an Altmetric Attention Score of 151. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2023.

All research outputs

#236,964

of 23,343,453 outputs

Outputs from Cochrane database of systematic reviews

#397

of 12,632 outputs

Outputs of similar age

#2,255

of 310,132 outputs

Outputs of similar age from Cochrane database of systematic reviews

of 234 outputs

Altmetric has tracked 23,343,453 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.

So far Altmetric has tracked 12,632 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.9. This one has done particularly well, scoring higher than 96% of its peers.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,132 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.

We're also able to compare this research output to 234 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.

Cochrane Database of Systematic Reviews

Chromium picolinate supplementation for overweight or obese adults

About this Attention Score

Mentioned by

Citations

Readers on

Twitter Demographics

Geographical breakdown

Demographic breakdown

Mendeley readers

Geographical breakdown

Demographic breakdown

Attention Score in Context